ArTS Archivio della ricerca di Trieste

ALESSIO, ENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.640
EU - Europa 11.738
AS - Asia 3.949
SA - Sud America 239
AF - Africa 91
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 18
Totale 34.701
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.531
DE - Germania 2.733
SE - Svezia 1.743
UA - Ucraina 1.579
IT - Italia 1.513
SG - Singapore 1.320
RU - Federazione Russa 1.049
CN - Cina 960
GB - Regno Unito 853
HK - Hong Kong 853
TR - Turchia 546
FI - Finlandia 544
PL - Polonia 513
BG - Bulgaria 291
IE - Irlanda 285
FR - Francia 204
BR - Brasile 192
NL - Olanda 124
IN - India 94
CA - Canada 88
CH - Svizzera 82
BE - Belgio 35
SN - Senegal 34
ES - Italia 33
AT - Austria 26
EU - Europa 26
VN - Vietnam 21
RO - Romania 20
CI - Costa d'Avorio 18
GR - Grecia 18
ID - Indonesia 18
CZ - Repubblica Ceca 17
AR - Argentina 16
JP - Giappone 16
PT - Portogallo 15
RS - Serbia 15
MX - Messico 14
SA - Arabia Saudita 14
EG - Egitto 13
ZA - Sudafrica 13
CL - Cile 12
AU - Australia 11
BD - Bangladesh 10
IR - Iran 10
JO - Giordania 10
TH - Thailandia 8
GE - Georgia 7
HU - Ungheria 7
NZ - Nuova Zelanda 7
EC - Ecuador 6
IQ - Iraq 6
LT - Lituania 6
TW - Taiwan 6
AZ - Azerbaigian 5
CO - Colombia 5
IL - Israele 5
KR - Corea 5
SK - Slovacchia (Repubblica Slovacca) 5
MY - Malesia 4
PA - Panama 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
BY - Bielorussia 3
CR - Costa Rica 3
HR - Croazia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LV - Lettonia 3
MA - Marocco 3
NO - Norvegia 3
PH - Filippine 3
PK - Pakistan 3
SI - Slovenia 3
BH - Bahrain 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
GH - Ghana 2
IS - Islanda 2
KE - Kenya 2
MD - Moldavia 2
NP - Nepal 2
QA - Qatar 2
TN - Tunisia 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
BW - Botswana 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
PE - Perù 1
TM - Turkmenistan 1
Totale 34.701
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.419
Ann Arbor 2.344
Fairfield 1.925
Houston 1.761
Jacksonville 1.396
Chandler 1.136
Wilmington 1.040
Ashburn 951
Hong Kong 843
Seattle 786
Singapore 709
Cambridge 649
Princeton 523
Izmir 494
Warsaw 490
Boardman 463
Trieste 312
Sofia 290
Beijing 284
Dublin 276
Columbus 252
Dearborn 222
Munich 200
Moscow 181
Santa Clara 180
Milan 166
San Diego 123
Düsseldorf 81
Redwood City 73
Verona 71
Bern 70
Helsinki 68
Mcallen 67
Hefei 55
Chicago 53
Buffalo 51
Mestre 49
Nanjing 49
Montréal 48
Des Moines 46
Phoenix 39
Guangzhou 38
Norwalk 36
Dakar 34
Kocaeli 34
Los Angeles 33
Kunming 32
Brussels 29
Frankfurt am Main 27
Dallas 24
Shanghai 24
The Dalles 24
Bremen 23
Rome 22
Andover 20
Jinan 19
Nanchang 19
Ottawa 19
Abidjan 18
Vienna 17
Wuhan 17
Zhengzhou 17
Falls Church 15
Naples 15
Chengdu 14
North Bergen 14
Florence 13
Shenyang 12
Washington 12
Athens 11
Bologna 11
Brno 11
Costa Mesa 11
Fuzhou 11
Hebei 11
Lisbon 11
Sacile 11
São Paulo 11
Venezia 11
Zurich 11
Auburn Hills 10
Bengaluru 10
Dagenham 10
Dong Ket 10
Edinburgh 10
Nuremberg 10
Berlin 9
Fremont 9
Hanoi 9
Lauterbourg 9
Redmond 9
Torre Del Greco 9
Aachen 8
Amsterdam 8
Baotou 8
Chennai 8
Erlangen 8
Lappeenranta 8
London 8
Polska 8
Totale 22.155
Salva come PNG Salva come JPEG
Nome #
Chimica Inorganica, seconda edizione italiana condotta sulla quinta edizione inglese 551
Neutral 1,3,5-Triaza-7-phosphaadamantane-Ruthenium(II) Complexes as Precursors for the Preparation of Highly Water-Soluble Derivatives 537
New Insight into a Deceptively Simple Reaction: The Coordination of bpy to RuII-Carbonyl Precursors - The Central Role of thefac-[Ru(bpy)Cl(CO)3]+Intermediate and theChloride Rebound Mechanism 338
New Cationic and Neutral Ru(II)- and Os(II)-dmso carbonyl Compounds 330
Synthetic strategies towards ruthenium-porphyrin conjugates for anticancer activity 306
1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for thepreparation of ruthenium complexes with potential anticancer activity 274
Side-to-face ruthenium porphyrin arrays. Photophysical behavior of dimeric and pentameric systems. 258
null 252
Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective 240
A noncovalently linked, dynamic fullerene porphyrin dyad. Efficient formation of long-lived charge separated states through complex dissociation. 231
New salts of anionic complexes of Ru(III) as antimetastatic and antineoplastic agents. 212
Palladium complexes with simple iminopyridines as catalysts for polyketone synthesis 204
Synthesis, Molecular Structure and Chemical Behavior of Hydrogen trans-bis(Dimethylsulfoxide)Tetrachlororuthenate(III) and mer-Trichlorotris(Dimethylsulfoxide)Ruthenium(III) - the First Fully Characterized Chloride Dimethylsulfoxide Ruthenium(III) Complexes 203
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry 202
Sulfoxide ruthenium complexes: non toxic tools for the selective treatment of solid tumour metastases. 200
Design of photoactivatable metallodrugs: Selective and rapid light-induced ligand dissociation from half-sandwich [Ru([9]aneS3)(N–N′)(py)]2+ complexes 196
The synthesis of RuBr2(DMSO)3 revisited: a mixture of Li[fac-RuClnBr3-n(DMSO)3] isomers (n = 0-3) is the reaction product 193
Discrete Supramolecular Assemblies of Porphyrins Mediated by Coordination Compounds 190
NAMI-A is highly cytotoxic toward leukaemia cell lines: evidence of inhibition of KCa 3.1 channels 188
Synthesis and characterization of new halogen -tetramethylene sulfoxide-ruthenium(II) and ruthenium(III) complexes; crystal structure of cis-dichlorotetrakis(tetramethylene sulfoxide) ruthenium(II) and hydrogen trans-bis(tetramethylene sulfoxide)tetrachlororuthenate(III) 187
New atropisomeric bidentate nitrogen-donor compounds as potential stereocontrollers in mild CO-styrene copolymerisation catalysed by palladium(II) salts. 186
Synthesis and Properties of Novel Fullerene Derivatives 186
Solution and solid state structure of a canted, side-to-face, bis-porphyrin adduct. 185
Response of MCa mammary carcinoma to cisplatin and to Na[trans-RuCl4(DMSO)(Im)]. 185
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 183
(15)N NMR spectroscopy unambiguously establishes the coordination mode of the diimine linker 2-(2'-pyridyl)pyrimidine-4-carboxylic acid (cppH) in Ru(II) complexes 183
Reduction of lung metastases by Na[trans-RuCl4(DMSO)Im] is not coupled with the induction of chemical xenogenization 182
Activation of Rh6(CO)16 with 1,10-phenanthroline and substituted derivatives in the catalytic reduction of nitrobenzene to aniline with carbon monoxide and water 181
Antitumor action of mer-trichlorobis(dimethyl sulfoxide)aminoruthenium(III) (BBR2382) in mice bearing Lewis lung carcinoma 180
The rare head-to-head conformation of untethered lopsided ligands discovered in both solution and solid states of 1,5,6-trimethylbenzimidazole Re(V) and Ru(II) complexes. 178
Chemical properties of rare platinum metal complexes having antitumor activity 178
Complessi dicarbossilati del rutenio(II) e loro impiego come antitumorali 176
trans-Ru(II)dimethylsulfoxides: antineoplastic action on mouse tumors 175
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 174
Ruthenium(III) complexes as antineoplastic agents. 172
NMR structural characterization of the reaction product between d(GpG) and the octahedral antitumor complex trans-RuCl2(DMSO)4. 172
Synthesis and characterization of a new series of palladium(II) compounds with nitrogen-donor chelating ligands: [Pd(chel)(L)2][PF6]2 171
Ruthenium anticancer compounds: challenges and expectations 170
Activation of carbonyl clusters with 1,10-phenanthroline and related ligands: the reduction of nitrobenzene as a model reac¬tion for MX(CO)Y (M = Ru, Os, Ir) + Phen systems as catalyst precursors 170
Carbonyl derivatives of chloride dimethyl-sulfoxide ruthenium(II) complexes. Synthesis, structural characterization, and reactivity of Ru(CO)(X)(Dmso)(4-X)Cl-2 complexes (X=1-3) 169
Rhodium(III) analogues of antitumour-active ruthenium(III) compounds: the crystal structure of [ImH][trans-RhCl4(Im)2] (Im= imidazole) 169
New half sandwich-type Ru(II) coordination compounds characterized by the fac-Ru(dmso-S)3 fragment: influence of the face-capping group on the chemical behavior and in vitro anticancer activity. 169
Tumor inhibition and effects on host survival time by rutheniumIII andrhodiumIII complexes with dimethylsulphoxide ligands. 167
Selective hydrogen transfer reactions from alcohols to ketones promoted by rhodium complexes with 1,10-phenanthroline and related ligands 167
A novel open-box shaped pentamer of vertically linked porphyrins that selectively recognizes S-bonded Me2SO complexes. 166
Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy 166
A categorization of metal anticancer compounds based on their mode of action. 165
A spectroscopic study of the reaction of NAMI, a novel ruthenium(III) anti-neoplastic complex, with bovine serum albumin 164
Wavelength-Dependent Electron and Energy Transfer Pathways in a Side-to-Face Ruthenium Porphyrin / Perylene Bisimide Assembly 164
Two-point self-coordination of a dizinc(ii) bis-pyridylporphyrin ruthenium complex leading selectively to a discrete molecular assembly: solution and solid state characterization 164
Biophysical analysis of natural, double-helical DNA modified by anticancer heterocyclic complexes of ruthenium(III) in cell-free media 163
Crystals containing conformers: a rare case in which a solid closely reflects a solution equilibrium mixture 163
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 162
Rare Example of Stereoisomeric 2 + 2 Metallacycles of Porphyrins Featuring Chiral-at-Metal Octahedral Ruthenium Corners 162
Porphyrin "flying saucers": Solid state and solution structure of a novelpentameric array of axially-ligated canted porphyrins. 161
The interaction of the antitumor complexes Na[trans-RuCl4(DMSO)(Im)] and Na[trans-RuCl4(DMSO)(Ind)] with apotransferrin: a spectroscopic study 161
Complessi trans di rutenio come agenti antineoplastici 160
Energy Transfer Pathways in Pyridylporphyrin Re(I) Adducts. 160
Towards Matched Pairs of Porphyrin-ReI/99mTcIConjugates that Combine Photodynamic Activity with Fluorescence and Radio Imaging 160
Photolabile Ru Model Complexes with Chelating Diimine Ligands for Light-Triggered Drug Release 160
Synthesis, structural characterization and chemical behavior of new dimeric Ru(III) complexes 159
Ruthenium-Porphyrin Conjugates with Cytotoxic and Phototoxic Antitumor Activity 157
Factors that influence the antiproliferative activity of half sandwich RuII-[9]aneS3 coordination compounds: activation kinetics and interaction with guanine derivatives. 157
Water-Soluble Ruthenium(II) Carbonyls with 1,3,5-Triaza-7-phosphoadamantane 157
Influence of the anionic ligands on the anticancer activity of Ru(II)-dmso complexes: Kinetics of aquation and in vitro cytotoxicity of new dicarboxylate compounds in comparison with their chloride precursors 156
Geometrical and linkage isomers of OsCl2(dmso)4: the complete picture 155
Na[trans-RuCl4(DMSO)(Im)]*2DMSO - antimetastatic ruthenium agent 154
Structure of trans-dichlorotetrakis(dimethyl sulfoxide)rhodium(III) tetrafluoroborate 154
Antineoplastic effects of mer-RuCl3(DMSO)2(NH3) against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4]. 154
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 154
Is the aromatic fragment of piano-stool ruthenium compounds an essential feature for anticancer activity? The development of new Ru(II)-[9]aneS3 analogues. 151
Complexed bridging ligands: oxorhenium(V) compounds with mono-coordinated pyrazine or pyrimidine as possible building-blocks for the construction of polynuclear architectures. 151
New geometrical and linkage isomers of the Ru(II) precursor cis,cis,trans-RuCl2(dmso-S)2(dmso-O)(CO): a spectroscopic and structural investigation 151
The Deceptively Similar Ruthenium(III) Drug Candidates KP1019 and NAMI-A Have Different Actions. What Did We Learn in the Past 30 Years? 151
COMPLESSI DI Ru(III) COME AGENTI ANTINEOPLASTICI 149
Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice. 149
Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an antimetastatic ruthenium complex 149
Steric properties of sulfoxide ligands. Synthesis and crystal-structure of mer-[RuCl3(Ph(2)SO)3] 149
Bioinorganic Medicinal Chemistry 149
The first example of a double bridged diruthenium(II) complex containing the rare bridging S,O bidentate dimethyl sulfoxide ligand which defines a stable Ru-Cl-Ru-S-O five-membered ring. 147
Metal-mediated multi-porphyrin discrete assemblies and their photoinduced properties. 147
New aspects of Rh(III)-dimethyl sulfoxide chemistry: synthesis and molecular structure of [NEt4][cis-RhCl4(DMSO)2] and chemical behaviour in aqueous solution of [RhCln(DMSO)6-n](3-n) (n = 3, 4) complexes. 147
Mixed-ligand rhenium(V) oxo monomers with triphenylphosphine oxide and lopsided and symmetrical heterocyclic ligands. Putative intermediates in rhenium(V) oxo synthetic chemistry 147
Novel Ru(III)-dimethyl sulfoxide catalysts for the selective oxidation of thioethers to sulfoxides with molecular oxygen 147
Antileukemic action of RuCl2(DMSO)4 isomers and prevention of brain involvement on P388 leukemia and on P388/DDP subline 147
Metal-mediated discrete supramolecular assemblies of porphyrins. 147
Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition 146
Novel Ruthenium Building Blocks for the Efficient Modular Construction of Heterobimetallic Molecular Squares of Porphyrins 146
Ordered supramolecular porphyrin arrays from a building block approach utilizing pyridylporphyrins and peripheral ruthenium complexes and identification of a new type of mixed-metal building block 145
Electronic Energy Transfer in a Multiporphyrin-based Molecular Box 145
Free exchange across cells,and echistatin-sensitive membrane target for the metastasis inhibitor NAMI-A(imidazolium trans-imidazole dimethyl sulfoxide tetrachlororuthenate)ON KB Tumor cells. 145
Carbonyl derivatives of chloride-dimethyl sulfoxide-ruthenium(III) complexes. Synthesis, crystal-structure, and reactivity of [(Dmso)(2)H][Trans-RuCl4(Dmso)(CO)] and mer, cis-RuCl3(Dmso)(2)(CO) 145
Comparison of the effects of the antimetastatic compound ImH[trans-RuCl4(DMSO)Im] (NAMI-A) on the arthritic rat and on MCa mammary carcinoma in mice 145
Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties 144
Treatment of metastases of solid mouse tumours by NAMI-A: comparison with cisplatin, cyclophosphamide and dacarbazine 144
New Water-Soluble Ruthenium(II) Terpyridine Complexes for Anticancer Activity: Synthesis, Characterization, Activation Kinetics, and Interaction with Guanine Derivatives 144
Phototoxic Activity and DNA Interactions of Water-Soluble Porphyrins and Their Rhenium(I) Conjugates 144
Metallacycles of Porphyrins as Building Blocks in the Construction of Higher Order Assemblies through Axial Coordination of Bridging Ligands: Solution- and Solid-State Characterization of Molecular Sandwiches and Molecular Wires 143
Synthesis and Reactivity of Ru-, Os-, Rh-, and Ir-halide-sulfoxide Complexes. 142
Synthesis and crystal structure of new Ru(III)-sulfoxide complexes containing a planar N-ligand: mer,cis-RuCl3(1Me-Im)(2)(S-DMSO) and [4Et-PyH][trans-RuCl4(4Et-Py)(S-DMSO)] 142
Totale 18.076
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.713
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.713
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.053 0 0 0 0 0 0 0 0 0 374 548 131
2020/20214.385 470 272 483 646 273 451 267 358 176 406 156 427
2021/20223.140 146 232 197 419 70 224 94 125 355 298 213 767
2022/20233.639 373 433 264 440 436 688 32 289 433 23 169 59
2023/20241.907 173 139 91 165 194 107 206 493 15 33 167 124
2024/20253.936 84 311 470 454 463 490 458 373 564 269 0 0
Totale 35.538